Mr. Klain named Pfizer as one of the companies the team would meet with but didn’t specify the others. The other drugmakers furthest along in COVID-19 vaccine development include Moderna, AstraZeneca and Johnson & Johnson.
“We’re going to have meetings between our top scientific advisers and the officials of these drug companies,” Mr. Klain told CNBC.
He stressed the importance of planning for vaccine distribution, saying: “It’s great to have a vaccine, but vaccines don’t save lives. Vaccinations save lives. And that means you’ve got to get that vaccine into people’s arms all over this country. It’s a giant logistical project.”
Read the full article here.
More articles on pharmacy:
HHS partners with 19 pharmacy networks for COVID-19 vaccine allocation
COVID-19 vaccines likely to have mild but painful side effects, scientists say
AstraZeneca says its cancer drug didn’t help COVID-19 patients in clinical trials
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.